Literature DB >> 3122836

Subunit structure of thrombin-activated human factor VIIIa.

P J Fay1.   

Abstract

Proteolytic activation of human Factor VIII (VIIIa) by thrombin was correlated with the generation of a light-chain-derived 73(71) kDa polypeptide plus polypeptides of 51 and 43 kDa derived from the heavy chain(s). Factor VIIIa activity was unstable and decayed to an inactive form (VIIIi) in the absence of additional proteolysis. The subunit structure of Factor VIIIa was studied using two rapid chromatographic methods. Gel filtration of Factor VIIIa showed that coagulant activity was correlated with the 73 and 51 kDa polypeptides which co-eluted with a Stokes radius of 46 A and was separated from the 43 kDa fragment. A similar polypeptide elution pattern was obtained for Factor VIIIi following prolonged incubation with thrombin. Gel filtration of EDTA-inactivated Factor VIIIa showed that the 73 and 51 kDa polypeptides eluted separately with Stokes radii of 32 and 38 A, respectively. Anion-exchange HPLC of Factor VIIIa resolved the coagulant-active 73/51 kDa dimer from the inactive dimer. The labile activity of Factor VIIIa was stabilized by chemical crosslinking reagents, presumably by formation of intra-chain crosslinks. A native Mr of 136,000 for Factor VIIIa, calculated from its Stokes radius (46 A) and sedimentation coefficient (7.1 S), was compatible with a non-covalent dimer composed of 73 and 51 kDa subunits.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3122836     DOI: 10.1016/0167-4838(88)90114-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Electron microscopy of human factor V and factor VIII: correlation of morphology with domain structure and localization of factor V activation fragments.

Authors:  W E Fowler; P J Fay; D S Arvan; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 2.  Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.

Authors:  R J Kaufman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

3.  Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.

Authors:  N Bihoreau; P Paolantonacci; C Bardelle; M P Fontaine-Aupart; S Krishnan; J Yon; J L Romet-Lemonne
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

4.  Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa.

Authors:  S W Pipe; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis.

Authors:  M W Mosesson; D N Fass; P Lollar; J P DiOrio; C G Parker; G J Knutson; J F Hainfeld; J S Wall
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  Thrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation.

Authors:  Matthew F Whelihan; Armin Kiankhooy; Kathleen E Brummel-Ziedins
Journal:  J Crit Care       Date:  2013-10-29       Impact factor: 3.425

Review 7.  Thrombin generation in hemorrhage control and vascular occlusion.

Authors:  Kenneth G Mann
Journal:  Circulation       Date:  2011-07-12       Impact factor: 29.690

Review 8.  Thrombin and vascular inflammation.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  Mol Cell Biochem       Date:  2011-08-23       Impact factor: 3.396

Review 9.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

10.  Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.

Authors:  S Layet; J P Girma; B Obert; E Peynaud-Debayle; N Bihoreau; D Meyer
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.